Sorrento Board Rejects Latest Acquisition Proposal
January 27, 2020 07:00 ET
|
Sorrento Therapeutics, Inc.
The latest non-binding proposal received on January 9, 2020 from a private equity fund to acquire a majority or all of the issued and outstanding shares of the company for “up to $7.00” per share...